Translational medicine is an interdisciplinary approach that integrates scientific understanding into portfolio decision making, with the goal of accelerating the discovery and development of new medicines for patients. Our translational medicine team works across therapeutic areas of focus and in collaboration with many functions throughout the organization to help analyze data, implement past learnings to guide clinical trials and ultimately expedite the time it takes to get potentially life-saving medicines to the patients who need them most. The translational medicine team at Bristol Myers Squibb primarily supports late-stage development. However, translational scientists are also embedded within research and early development to perform exploratory analyses relevant to our pre-clinical and early-stage pipelines.
Translational Medicine – Process, Opportunity, Pillars
There are several reasons we believe we’re performing industry-leading translational medicine research at Bristol Myers Squibb. First and foremost, we have a talented roster of scientists who are committed to making discoveries that will transform patients’ lives. In addition, we have a robust portfolio of assets in clinical studies across disease areas, providing us with a treasure-trove of information that we can leverage for future research. And last, but not least, is how we use the data and insights we uncover. Ultimately, our goal in translational medicine is to provide information that helps our researchers follow the science – wherever it may take them – in order to discover and develop therapies for patients in need.
Our unique approach to translational medicine can be categorized into three “pillars,” or broad areas of focus.